<?xml version="1.0" encoding="UTF-8"?>
<p>Coronaviruses have evolved since history from MERS-CoV, SARS-CoV-1 and SARS-CoV-2 causing threat to human population. There is absence of specific drugs for the cure, many studies have carried out underlying the importance of existing viral drugs that were used for HIV or Ebola viruses or for the development of medicinal herbs as drugs against this virus till as the world is waiting for the development of vaccine. The presence of existing life-threatening disorders to an individual like diabetes, cardiovascular diseases and obesity are prone to worsen the COVID-19 complications. Research and development on SARS and MERS may offer insights that would be beneficial to the development of therapeutic and preventive agents for COVID-19. Identification of targets is important for identifying drugs with high target specificity and/or uncovering existing drugs that could be repurposed to treat SARS-CoV-2 infections (Dhama et al., 
 <xref rid="CIT0006" ref-type="bibr">2020</xref>; Harrison, 
 <xref rid="CIT0007" ref-type="bibr">2020</xref>; Kilanski &amp; Baker, 
 <xref rid="CIT0012" ref-type="bibr">2015</xref>; Li &amp; Clercq, 
 <xref rid="CIT0013" ref-type="bibr">2020</xref>; Lin et al., 
 <xref rid="CIT0014" ref-type="bibr">2020</xref>; Mandadapu et al., 
 <xref rid="CIT0017" ref-type="bibr">2013</xref>; Prajapat et al., 
 <xref rid="CIT0023" ref-type="bibr">2020</xref>; Prasanth et al., 
 <xref rid="CIT0024" ref-type="bibr">2020</xref>; Solaimanzadeh, 
 <xref rid="CIT0030" ref-type="bibr">2020</xref>; Totura &amp; Bavari, 
 <xref rid="CIT0034" ref-type="bibr">2019</xref>; Trott &amp; Olson, 
 <xref rid="CIT0035" ref-type="bibr">2020</xref>; Wishart et al., 
 <xref rid="CIT0039" ref-type="bibr">2006</xref>; Yang et al., 
 <xref rid="CIT0040" ref-type="bibr">2020</xref>; Zhang et al., 
 <xref rid="CIT0041" ref-type="bibr">2020</xref>; Zhou et al., 
 <xref rid="CIT0042" ref-type="bibr">2020</xref>).
</p>
